Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Net Cash Flow (2023 - 2025)

Historic Net Cash Flow for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to -$149.0 million.

  • Nuvation Bio's Net Cash Flow fell 414907.33% to -$149.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.8 million, marking a year-over-year increase of 97500.4%. This contributed to the annual value of -$7.4 million for FY2024, which is 8737.55% up from last year.
  • According to the latest figures from Q3 2025, Nuvation Bio's Net Cash Flow is -$149.0 million, which was down 414907.33% from $200.1 million recorded in Q2 2025.
  • In the past 5 years, Nuvation Bio's Net Cash Flow registered a high of $200.1 million during Q2 2025, and its lowest value of -$149.0 million during Q3 2025.
  • Moreover, its 3-year median value for Net Cash Flow was -$303000.0 (2024), whereas its average is -$238181.8.
  • Over the last 5 years, Nuvation Bio's Net Cash Flow had its largest YoY gain of 6614653.47% in 2025, and its largest YoY loss of 414907.33% in 2025.
  • Over the past 3 years, Nuvation Bio's Net Cash Flow (Quarter) stood at $18.3 million in 2023, then crashed by 74.96% to $4.6 million in 2024, then plummeted by 3360.72% to -$149.0 million in 2025.
  • Its last three reported values are -$149.0 million in Q3 2025, $200.1 million for Q2 2025, and $12.1 million during Q1 2025.